Abstract:RationaleProteomics and metabolomics are widely used in the study of diabetes, but rarely in prediabetes research. This study aimed to explore the mechanisms of early-onset type 2 diabetes mellitus (T2DM) by analyzing proteomic changes at different stages of glucose metabolism. MethodsA total of 40 individuals undergoing routine physical health examinations between December 2016 and April 2017 were enrolled. Subjects were divided into four groups based on fasting blood glucose (FPG) levels: FPG < 5.6 mmol/L (group A); FPG >= 5.6 mmol/L and <6.1 mmol/L (group B); FPG >= 6.1 mmol/L and <7.0 mmol/L (group C); and FPG >= 7.0 mmol/L (group D). Each group had 10 cases. Sera from these 40 subjects were analyzed by label-free quantitative liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS). LC/MS/MS with selected reaction monitoring mode was also performed for qualitative and quantitative metabolomics analysis. Differentially expressed proteins were identified. Partial least squares discriminant analysis (PLS-DA) and orthogonal partial least squares discriminant analysis (OPLS-DA) were used to analyze the differentially expressed metabolites. ResultsA total of 202 differentially expressed proteins were screened and were identified as mainly secreted proteins. Comparing group A with group B, 32 proteins were up-regulated and 18 proteins were down-regulated. Comparing group A with group C, 24 proteins were up-regulated and 24 proteins were down-regulated. Comparing group A with group D, 19 proteins were up-regulated and 17 proteins were down-regulated. The fold change for up-regulated proteins was >1.2, p < 0.05, while the fold change for down-regulated proteins was <-1.2, p < 0.05. PLS-DA and OPLS-DA revealed 113 differentially expressed metabolites. Correlation analysis of differentially expressed metabolites of group A versus group B revealed that among the down-regulated differential proteins, transforming growth factor beta-induced protein ig-h3 correlated negatively with metabolite L-saccharin, while among the up-regulated differential proteins, apolipoprotein C-IV correlated negatively with metabolite 3-methyloxindole. Among all differentially expressed proteins, 19 proteins were associated with early initiation of chronic inflammation, including CD14 and CSF-1R, which were newly identified in the early onset of T2DM. ConclusionsMany proteins are differentially expressed between prediabetes and after T2DM diagnosis, although the specific mechanism remains unclear. The expression level of CD14 was significantly up-regulated and that of CSF-1R was significantly down-regulated when FPG was >= 5.6 mmol/L, suggesting that CD14 and CSF-1R may be important markers for early-onset T2DM and may serve as new targets for T2DM treatment.

Peptide Markers for Apolipoprotein A -I of Plasma Modified by Glucose

A study on modification of Human Albumin by proteomic technique

Analysis of Protein Expression Changes in Patients with Prediabetes Using Proteomics Approaches.

Lc-Ms Analysis Of Markers For Advanced Glycation Endproducts-Protein/Peptides Adducts

The Determination of AGE-peptides by Flow Injection Assay, a Practical Marker of Diabetic Nephropathy.

A New Strategy For Early Diagnosis Of Type 2 Diabetes By Standard-Free, Label-Free Lc-Ms/Ms Quantification Of Glycated Peptides

Profiling Plasma Peptides for the Identification of Potential Ageing Biomarkers in Chinese Han Adults

Application of a Pseudotargeted MS Method for the Quantification of Glycated Hemoglobin for the Improved Diagnosis of Diabetes Mellitus

Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer's Disease—A Feasibility Study

Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older Adults

Establishment and Optimization of Peptide Biomarker Screening Model in Diabetes in Vitro by HPLC/ESI-TOF Mass Spectrometry

Quantitative Determination of the Glycosylation Level for the Binding Proteins to High Density Lipoprotein by Mass Spectrometry

Association Of Serum Lipid Metabolism With Markers Of Urinary Peptides In Type 2 Diabetes Patients

AGEs and chronic subclinical inflammation in diabetes: disorders of immune system.

Value of Serum Advanced Glycation End Products-Peptide in the Screening of Diabetes Mellitus in a Community-Based Population of High-Risk Diabetics

Identification Of Age-Precursors Andage Formation In Glycation-Induced Bsa Peptides

Discovery and validation of glucose-sensitive peptide biomarkers from human serum albumin to diagnose type 2 diabetes mellitus

Protein Expressions of Plasma Adipocyte Fatty Acid Binding Protein 4 and Phosphatase and Tensin Homolog Deleted on Chromosome Ten and Their Correlation with Insulin Resistance in Patients with Impaired Glucose Regulation and Newly Diagnosed Type 2 Diabete

Discovery of age-related early-stage glycated proteins based on deep quantitative serum glycated proteome analysis

Proteomics Study on Cross-Linking Reaction of Formaldehyde and Hsa

The Tryptic Peptides of Hemoglobin for Diagnosis of Type 2 Diabetes Mellitus Using Label-Free and Standard-Free LC-ESI-DMRM